FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294554402> ?p ?o ?g. }

• W4294554402 endingPage "185" @default.
• W4294554402 startingPage "173" @default.
• W4294554402 abstract "Abstract Background Several biological treatments have become available for management of severe asthma. There is a significant overlap in the indication of these treatments with lack of consensus on the first‐line biologic choice and switching practice in event of treatment failure. Aims To evaluate outcomes of biologic treatments through analysis of the UK Severe Asthma Registry (UKSAR), and survey of the UK severe asthma specialists' opinion. Methods Patients registered in the UKSAR database and treated with biologics for severe asthma in the period between January 2014 and August 2021, were studied to explore biologic treatments practice. This was complemented by survey of opinion of severe asthma specialists. Results A total of 2490 patients from 10 severe asthma centres were included in the study (mean age 51.3 years, 61.1% female, mean BMI 30.9 kg/m 2 ). Biologics use included mepolizumab 1115 (44.8%), benralizumab 925 (37.1%), omalizumab 432 (17.3%), dupilumab 13 (0.5%) and reslizumab 5 (0.2%). Patients on omalizumab were younger and had earlier age of onset asthma than those prescribed mepolizumab or benralizumab. Patients prescribed mepolizumab and benralizumab had similar clinical characteristics. Those on benralizumab were more likely to continue treatment at approximately one year follow‐up (93.9%), than those on mepolizumab (80%), or omalizumab (69.6%). The first‐choice biologic differed between centres and changed over the study time period. Experts' opinion also diverged in terms of biologic initiation choice and switching practice. Conclusion We observed significant variation and divergence in the prescribing practices of biologics in severe asthma that necessitates further research and standardization." @default.
• W4294554402 created "2022-09-04" @default.
• W4294554402 creator A5000037287 @default.
• W4294554402 creator A5004556588 @default.
• W4294554402 creator A5009297900 @default.
• W4294554402 creator A5011606845 @default.
• W4294554402 creator A5016521386 @default.
• W4294554402 creator A5017808438 @default.
• W4294554402 creator A5022389916 @default.
• W4294554402 creator A5022973190 @default.
• W4294554402 creator A5028161444 @default.
• W4294554402 creator A5028976385 @default.
• W4294554402 creator A5033806625 @default.
• W4294554402 creator A5035503350 @default.
• W4294554402 creator A5038685511 @default.
• W4294554402 creator A5050695896 @default.
• W4294554402 creator A5053446150 @default.
• W4294554402 creator A5053503008 @default.
• W4294554402 creator A5055964884 @default.
• W4294554402 creator A5064411220 @default.
• W4294554402 creator A5073147866 @default.
• W4294554402 creator A5076371917 @default.
• W4294554402 creator A5078489750 @default.
• W4294554402 date "2022-09-17" @default.
• W4294554402 modified "2023-09-26" @default.
• W4294554402 title "Biologic therapy practices in severe asthma; outcomes from the <scp>UK</scp> Severe Asthma Registry and survey of specialist opinion" @default.
• W4294554402 cites W2061435251 @default.
• W4294554402 cites W2094189191 @default.
• W4294554402 cites W2097981132 @default.
• W4294554402 cites W2177181431 @default.
• W4294554402 cites W2273087118 @default.
• W4294554402 cites W2637940744 @default.
• W4294554402 cites W2805002966 @default.
• W4294554402 cites W2912559110 @default.
• W4294554402 cites W2920867278 @default.
• W4294554402 cites W2973224637 @default.
• W4294554402 cites W2977205771 @default.
• W4294554402 cites W2984566094 @default.
• W4294554402 cites W3006232060 @default.
• W4294554402 cites W3009509122 @default.
• W4294554402 cites W3011761745 @default.
• W4294554402 cites W3049165135 @default.
• W4294554402 cites W3082062213 @default.
• W4294554402 cites W3093535691 @default.
• W4294554402 cites W3110668323 @default.
• W4294554402 cites W3120999076 @default.
• W4294554402 cites W3124157949 @default.
• W4294554402 cites W3157365672 @default.
• W4294554402 cites W3184501609 @default.
• W4294554402 cites W4225962436 @default.
• W4294554402 doi "https://doi.org/10.1111/cea.14222" @default.
• W4294554402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36057784" @default.
• W4294554402 hasPublicationYear "2022" @default.
• W4294554402 type Work @default.
• W4294554402 citedByCount "1" @default.
• W4294554402 countsByYear W42945544022023 @default.
• W4294554402 crossrefType "journal-article" @default.
• W4294554402 hasAuthorship W4294554402A5000037287 @default.
• W4294554402 hasAuthorship W4294554402A5004556588 @default.
• W4294554402 hasAuthorship W4294554402A5009297900 @default.
• W4294554402 hasAuthorship W4294554402A5011606845 @default.
• W4294554402 hasAuthorship W4294554402A5016521386 @default.
• W4294554402 hasAuthorship W4294554402A5017808438 @default.
• W4294554402 hasAuthorship W4294554402A5022389916 @default.
• W4294554402 hasAuthorship W4294554402A5022973190 @default.
• W4294554402 hasAuthorship W4294554402A5028161444 @default.
• W4294554402 hasAuthorship W4294554402A5028976385 @default.
• W4294554402 hasAuthorship W4294554402A5033806625 @default.
• W4294554402 hasAuthorship W4294554402A5035503350 @default.
• W4294554402 hasAuthorship W4294554402A5038685511 @default.
• W4294554402 hasAuthorship W4294554402A5050695896 @default.
• W4294554402 hasAuthorship W4294554402A5053446150 @default.
• W4294554402 hasAuthorship W4294554402A5053503008 @default.
• W4294554402 hasAuthorship W4294554402A5055964884 @default.
• W4294554402 hasAuthorship W4294554402A5064411220 @default.
• W4294554402 hasAuthorship W4294554402A5073147866 @default.
• W4294554402 hasAuthorship W4294554402A5076371917 @default.
• W4294554402 hasAuthorship W4294554402A5078489750 @default.
• W4294554402 hasBestOaLocation W42945544021 @default.
• W4294554402 hasConcept C126322002 @default.
• W4294554402 hasConcept C141105273 @default.
• W4294554402 hasConcept C159654299 @default.
• W4294554402 hasConcept C177713679 @default.
• W4294554402 hasConcept C187212893 @default.
• W4294554402 hasConcept C203014093 @default.
• W4294554402 hasConcept C2776042228 @default.
• W4294554402 hasConcept C2777037409 @default.
• W4294554402 hasConcept C2777832160 @default.
• W4294554402 hasConcept C2778564945 @default.
• W4294554402 hasConcept C2779185760 @default.
• W4294554402 hasConcept C3020580240 @default.
• W4294554402 hasConcept C512399662 @default.
• W4294554402 hasConcept C71924100 @default.
• W4294554402 hasConceptScore W4294554402C126322002 @default.
• W4294554402 hasConceptScore W4294554402C141105273 @default.
• W4294554402 hasConceptScore W4294554402C159654299 @default.
• W4294554402 hasConceptScore W4294554402C177713679 @default.
• W4294554402 hasConceptScore W4294554402C187212893 @default.

• next